Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs
A retrospective review of acute myeloid leukaemia in 35 dogs diagnosed by a combination of morphologic findings, flow cytometric immunophenotyping and cytochemical staining results (2007–2015)
Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour
Preliminary investigation of blood concentrations of insulin-like growth factor, insulin, lactate and β-hydroxybutyrate in dogs with lymphoma as compared with matched controls
Outcome of 9 dogs treated with stereotactic radiation therapy for primary or metastatic vertebral osteosarcoma
Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors
The role of sentinel lymph node mapping in small animal veterinary medicine: A comparison with current approaches in human medicine
Retrospective analysis of factors affecting clinical outcome following CHOP-based chemotherapy in dogs with primary nodal diffuse large B-cell lymphoma
Faecal microbiota in dogs with multicentric lymphoma
Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers
Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours
A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma
Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs
Liposome-encapsulated chemotherapy: Current evidence for its use in companion animals
Feline vaccine-associated sarcomagenesis: Is there an inflammation-independent role for aluminium?
Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs
Increased frequency of CD45 negative T cells (T zone cells) in older Golden retriever dogs
Novel hyperthermia applicator system allows adaptive treatment planning: Preliminary clinical results in tumour-bearing animals
Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses
Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma
Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma
Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target
Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs
Principles for ethical treatment decision-making in veterinary oncology
Characterization of a low expression haplotype in canine glutathione S-transferase (GSTT1) and its prevalence in golden retrievers
Prior joint disease is associated with increased risk of periarticular histiocytic sarcoma in dogs
Transcriptomic profile reveals molecular events associated to focal adhesion and invasion in canine mammary gland tumour cell lines
Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study
Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma
Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016)
Patient characteristics, prognostic factors and outcome of dogs with high-grade primary mediastinal lymphoma
Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas
A dose-escalation study of combretastatin A4-phosphate in healthy dogs
Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma
Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy
Apoptotic intrinsic pathway proteins predict survival in canine cutaneous mast cell tumours
In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines
Outcome following treatment of feline gastrointestinal mast cell tumours
Feline large granular lymphocyte lymphoma: An Italian Society of Veterinary Oncology (SIONCOV) retrospective study
Comparison of histologic margin status in low-grade cutaneous and subcutaneous canine mast cell tumours examined by radial and tangential sections
Prognostic significance of morphotypes in canine lymphomas: A systematic review of literature
Metastatic diagnosis of canine sternal lymph nodes using computed tomography characteristics: A retrospective cross-sectional study
Metastasis-associated microRNA expression in canine uveal melanoma
LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma
Expression and targeting of transcription factor ATF5 in dog gliomas
Intratumoral injection of radioactive holmium (166Ho) microspheres for treatment of oral squamous cell carcinoma in cats
Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs
The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma
Effectiveness of CO2 laser in an experimental mammary gland adenocarcinoma model
Bosutinib, an SRC inhibitor, induces caspase-independent cell death associated with permeabilization of lysosomal membranes in melanoma cells
The use of low-dose metronomic chemotherapy in dogs—insight into a modern cancer field
Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study
Comparative analysis of DNA methylation patterns of equine sarcoid and healthy skin samples
Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi-institutional retrospective study of 64 cases